$3B Lilly Case Spotlights Drug Promoters' Labeling Quandary
A Louisiana federal judge's decision to uphold a jury verdict awarding $3 billion in punitive damages against Eli Lilly & Co. in an Actos personal injury trial sends a stark warning...To view the full article, register now.
Already a subscriber? Click here to view full article